The unnecessary deaths and damage when safer, simpler and cost effective solutions exist is pathological.
Trials on a new Ebola vaccine developed by Merck and NewLink were suspended by Geneval University Hospital after four volunteers reported unexpected side effects.
Four participants reported join pain ten to fourteen days after an injection.
Professor Laurent Kaiser said that many of the volunteers for the Merck NewLink Ebola vaccine trial in Geneva were doctors, and so able to report side effects more precisely.
Kaiser noted other clinical trials had not reported side effects but they had given volunteers smaller doses and also had yet to reach the 10 to 14 day mark when the side affects appeared.
The trials will resume on January on up to 15 of the original 59 volunteers, after checks to ensure that the joint pain symptoms in hands and feet were temporary and benign.
The trial suspension is a setback for WHO plans to give the experimental Canadian and GSK Ebola vaccine to thousands of…
View original post 33 more words